Skip to content
Medxy AI
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • Wellness & Lifestyle
  • Clinical Updates
  • Medical News
  • MedXY story
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Spironolactone
Dapagliflozin and Spironolactone: A Promising Combination for Heart Failure with Preserved Ejection Fraction
Posted inClinical Updates Wellness & Lifestyle

Dapagliflozin and Spironolactone: A Promising Combination for Heart Failure with Preserved Ejection Fraction

Posted by By MedXY 08/11/2025
The SOGALDI-PEF trial evaluates the effects of dapagliflozin combined with spironolactone versus dapagliflozin alone in patients with heart failure, revealing significant improvements in NT-proBNP levels and safety concerns.
Read More
  • Optimizing Hypertension Management Through Remote Monitoring: Insights from a Randomized Controlled Trial
  • Exploring the Link Between the Triglyceride-Glucose Index and Hypertension Incidence in Japanese Adults
  • Revisiting Women’s Health: Pregnancy Complications and Long-Term Stroke Risk
  • Examining the Link Between Obesity and Kidney Outcomes in Heart Failure with Preserved Ejection Fraction
  • Improving Patient Safety: The Role of Deprescribing Diabetes Medication in Older Adults
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • English
  • 日本語
  • Tiếng Việt
  • 中文

aging Alzheimer's disease artificial intelligence blood pressure breast cancer cardiovascular health cardiovascular risk clinical trial clinical trials COPD Dementia diabetes diet epidemiology exercise health HPV Hypertension immunotherapy inflammation ketogenic diet lifestyle longevity MASLD men's health mental health multiple myeloma NAFLD nutrition obesity phòng ngừa Pregnancy prevention public health randomized controlled trial randomized trial sexual health sleep stroke sức khỏe treatment type 2 diabetes weight loss wellness women's health

Your health, we care

Copyright 2025 — Medxy AI. All rights reserved.
Scroll to Top